Avulunga Pty. , Ltd.

Avulunga Pty., Ltd. specializes in the BELSCOPE LARYNGOSCOPE, a device designed for visual examination of the larynx and adjacent anatomical structures during medical procedures. This device is intended for use in clinical settings where direct visualization of the airway is required.

Avulunga Pty., Ltd. is headquartered in the United States. The company’s location is relevant for regulatory compliance and market access, particularly in jurisdictions where domestic manufacturers may have distinct requirements.

The BELSCOPE LARYNGOSCOPE produced by Avulunga Pty., Ltd. is classified as a Class I medical device under US regulatory standards. This classification typically applies to devices posing minimal risk to patients, often due to their non-invasive nature or lack of significant energy transfer. Class I devices generally undergo less stringent regulatory oversight compared to higher-risk categories.

Yes, the BELSCOPE LARYNGOSCOPE is listed under the FDA’s 510(k) pathway, which is a premarket notification process for Class I and some Class II devices. This pathway demonstrates that the device meets the regulatory requirements for safety and effectiveness by either being substantially equivalent to a legally marketed predicate device or complying with applicable performance standards.